Literature DB >> 963343

The effects of morphine on the release of noradrenaline from the mouse vas deferens.

G Henderson, J Hughes.   

Abstract

Electrical field stimulation of the mouse vas deferens (TO and C57/BL strains) caused the release of noradrenaline into the bathing medium. 2 Phenoxybenzamine (30 muM) or phentolamine (36 muM) plus cocaine (13 muM) caused a considerable increase in the noradrenaline output. 3 In the vasa deferentia from TO mice the output per pulse of noradrenaline was constant at frequencies of stimulation from 0.5 to 15 Hz whereas in the vasa deferentia from C57/BL mice the output per pulse of noradrenaline increased two-fold from 1.5 to 15 Hz. 4 Morphine (2 muM) inhibited the contractions of the vasa deferentia from TO mice. This effect was greater at low (0.1-1 Hz) than at high (10 Hz) frequencies of stimulation. Morphine (2 muM) did not inhibit the response of the tissue to exogenous noradrenaline. 5 Morphine (1 muM) reduced the noradrenaline output from the vasa deferentia of TO mice stimulated at 1.5 Hz but did not reduce the noradrenaline output at 15 Hz. At 1.5 Hz the reduction of noradrenaline output was reversed by naloxone (0.05 muM). 6 Morphine (5 muM) did not inhibit the uptake of [3H]-noradrenaline into the vasa deferentia from TO mice. 7 Only in high concentrations (ID50 30.88 muM) did morphine inhibit the contractions of the vasa deferentia from C57/BL mice. 8 Normorphine (100 muM) did not reduce the noradrenaline output from vasa deferentia of C57/BL mice.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963343      PMCID: PMC1667048          DOI: 10.1111/j.1476-5381.1976.tb10384.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum.

Authors:  A A Waterfield; H W Kosterlitz
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

3.  CELLULAR INTERRELATIONSHIPS AND ELECTRICAL ACTIVITY IN TWO TYPES OF SMOOTH MUSCLE.

Authors:  B P LANE; J A RHODIN
Journal:  J Ultrastruct Res       Date:  1964-06

4.  Noradrenaline and motor transmission in the vas deferens of the mouse.

Authors:  M E Jones; T L Spriggs
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

5.  Proceedings: Modulation of frequency-dependent noradrenaline release by calcium, angiotensin and morphine.

Authors:  G Henderson; J Hughes
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

6.  Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens.

Authors:  J B Furness; G R Campbell; S M Gillard; T Malmfors; J L Cobb; G Burnstock
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

7.  Evidence against adrenergic motor transmission in the guinea-pig vas deferens.

Authors:  N Ambache; M A Zar
Journal:  J Physiol       Date:  1971-07       Impact factor: 5.182

8.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

9.  Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.

Authors:  J Hughes; H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

10.  Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

View more
  14 in total

1.  Clonidine and morphine increase [3H]-noradrenaline overflow in mouse vas deferens.

Authors:  K M Forsyth; D Pollock
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

2.  Pharmacological differentiation of presynaptic inhibitory alpha-adrenoceptors and opiate receptors in the cat nictitating membrane.

Authors:  M L Dubocovich; S Z Langer
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

3.  Importance of frequency and pulse with in field stimulation of the mouse vas deferens: different behaviour of twitch-inhibiting drugs.

Authors:  G Zetler; M Kaschube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

4.  Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus.

Authors:  J C McGrath
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

5.  The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

6.  Theophylline does not affect morphine inhibition of the isolated vas deferens.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

7.  A study of the role of cyclic adenosine 3',5'-monophosphate in the depression by opiates and opioid peptides of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens.

Authors:  M R Bennett; N A Lavidis
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

9.  The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

10.  The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.